[HTML][HTML] Newly identified deficiencies in the multiple sclerosis central nervous system and their impact on the remyelination failure

G Scalabrino - Biomedicines, 2022 - mdpi.com
The pathogenesis of multiple sclerosis (MS) remains enigmatic and controversial. Myelin
sheaths in the central nervous system (CNS) insulate axons and allow saltatory nerve …

Low levels of cobalamin, epidermal growth factor, and normal prions in multiple sclerosis spinal cord

G Scalabrino, D Veber, R De Giuseppe, F Roncaroli - Neuroscience, 2015 - Elsevier
We have previously demonstrated that multiple sclerosis (MS) patients have abnormal
cerebrospinal fluid (CSF) levels of the key myelin-related molecules cobalamin (Cbl) …

[HTML][HTML] The molecular basis for remyelination failure in multiple sclerosis

J Gruchot, V Weyers, P Göttle, M Förster, HP Hartung… - Cells, 2019 - mdpi.com
Myelin sheaths in the central nervous system (CNS) insulate axons and thereby allow
saltatory nerve conduction, which is a prerequisite for complex brain function. Multiple …

[PDF][PDF] Current knowledge of multiple sclerosis pathogenesis

E Zaprianova, D Deleva, B Sultanov… - Acta morphol. et …, 2009 - iempam.bas.bg
The purpose of this review is to highlight the new concepts of the mechanisms of multiple
sclerosis (MS) pathogenesis. For many years MS was considered to be primary …

Inherited and acquired disorders of myelin: the underlying myelin pathology

ID Duncan, AB Radcliff - Experimental neurology, 2016 - Elsevier
Remyelination is a major therapeutic goal in human myelin disorders, serving to restore
function to demyelinated axons and providing neuroprotection. The target disorders that …

Neurodegeneration in multiple sclerosis

GM Mey, KR Mahajan… - WIREs mechanisms of …, 2023 - Wiley Online Library
Axonal loss in multiple sclerosis (MS) is a key component of disease progression and
permanent neurologic disability. MS is a heterogeneous demyelinating and …

Multiple sclerosis-remyelination failure as a cause of disease progression

K Hagemeier, W Brück, T Kuhlmann - 2012 - digitum.um.es
Multiple sclerosis (MS) is the most frequent demyelinating disease of the central nervous
system (CNS) that affects worldwide about 2.5 million people. The morphological correlates …

Chronic demyelination and axonal degeneration in multiple sclerosis: pathogenesis and therapeutic implications

TJ Simkins, GJ Duncan, D Bourdette - Current neurology and …, 2021 - Springer
Abstract Purpose of Review Multiple sclerosis (MS) is the most common demyelinating
disease of the central nervous system (CNS). Inflammatory attacks in MS lead to both …

Role of oligodendrocyte dysfunction in demyelination, remyelination and neurodegeneration in multiple sclerosis

AO Dulamea - Multiple Sclerosis: Bench to Bedside: Global …, 2017 - Springer
Oligodendrocytes (OLs) are the myelinating cells of the central nervous system (CNS) during
development and throughout adulthood. They result from a complex and well controlled …

Recent advances in the neuropathology of multiple sclerosis

C Stadelmann - Revue neurologique, 2007 - Elsevier
Important insights from multiple sclerosis (MS) pathology have broadened our view of the
disease during the last years. Details of the inflammatory response as well as mechanisms …